Outlook on the Liquid Biopsy Global Market to 2025 - Aging Population and Lower Costs are Driving Growth

Research and Markets
·9 min read

Dublin, Nov. 23, 2020 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2021-2025" report has been added to ResearchAndMarkets.com's offering.

The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the impact of the COVID-19 pandemic on the Liquid Biopsy market? This report provides a detailed analysis.

Circulating Tumor Cells? Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.

A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.

GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The company is now working on a 10,000-plus subject study, called the Circulating Cell-Free Genome Atlas (CCGA) to help identify cancer early. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has just moved out of the development phase and into the growth phase. The impact on the health care industry is enormous. The report forecasts the market size out to 2024. In addition, the report looks at potential market sizes by country, by cancer and by the four types of usage: screening, diagnosis, therapy selection and recurrence monitoring.

The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring.

Key Topics Covered:

1. Introduction and Market Definition
1.1 What is Liquid Biopsy?
1.2 The Sequencing Revolution
1.3 Market Definition
1.3.1 Revenue Market Size
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 A Spending Perspective on Liquid Biopsy
1.5.1 An Historical Look at Clinical Testing

2. Market Overview
2.1 Players in a Dynamic Market
2.1.1 Academic Research Lab
2.1.2 Diagnostic Test Developer
2.1.3 Genomic Instrumentation Supplier
2.1.3.1 Cell Separation and Viewing Instrumentation Supplier
2.1.4 Pharmaceutical/Reagent Supplier
2.1.5 Independent Testing Lab
2.1.6 Public National/regional lab
2.1.7 Hospital lab
2.1.8 Physician Lab
2.1.9 Audit Body
2.1.10 Certification Body
2.2 Using Biopsies
2.2.1 Cancer
2.2.2 Precancerous conditions
2.2.3 Inflammatory conditions
2.3 Biopsy Sites
2.4 The Situation Today - Biopsy Analysis
2.5 Evidence of Cancer - Liquid Biopsy Technology
2.5.1 The Big Picture on Liquid Biopsy Technology
2.5.2 The Role of CTCs
2.5.2.1 Types of CTCs
2.5.2.2 CellSearch Detection- Ultimate Sensitivity
2.5.2.3 Epic Sciences Detection- Imaging Takes the Lead
2.5.2.4 Maintrac Detection - The Microscope
2.5.2.5 Other Methods
2.5.3 ctDNA - Going Mainstream?
2.5.4 Exosomes and Micro Vesicles - New Kid on the Block
2.5.5 The Multiple Play
2.6 Cancer Treatment Protocol Under Siege
2.6.1 Issues to Liquid Biopsy Adoption - Double Diagnostics
2.6.2 The Cancer Screening Market Opportunity
2.6.2.1 GRAIL - What Is It?
2.6.3 Cancer Management vs. Diagnosis
2.6.3.1 The Role of Risk Assessment
2.6.3.2 Managing Therapy
2.6.3.3 Monitoring Disease - What Is It?
2.6.4 Phases of Adoption - Looking into The Future
2.6.5 The Promise of Liquid Biopsy
2.7 Structure of Industry Plays a Part
2.7.1 Hospital Testing Share
2.7.2 Economies of Scale
2.7.2.1 Hospital vs. Central Lab
2.7.3 Physician Office Lab's
2.7.4 Physician's and POCT

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Non Invasive Game Changer
3.1.2 Lower Cost
3.1.3 Greater Accuracy
3.1.4 Wide Range of Potential Uses
3.1.5 Aging Population
3.2 Factors Limiting Growth
3.2.1 Lower prices
3.2.2 Lack of Standards
3.2.3 Protocol Resistance
3.2.4 Initial Adoption Cost
3.2.5 COVID-19
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.1 Next Generation Sequencing Fuels a Revolution
3.4.2 Impact of NGS on pricing
3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.4 CGES Testing, A Brave New World
3.4.5 Biochips/Giant magnetoresistance based assay

4. Liquid Biopsy Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section

  • Liquid Biopsy NGS Panels - Diverse Test Claims

  • CMS Colon Cancer Screening Memo Bodes Well for Assays

  • Natera Liquid Biopsy Test Coverage to Expand

  • Freenome Closes Financing to Support Early Cancer Detection Trial

  • C$2.6M Liquid Biopsy Initiative

  • NeoGenomics, Inivata Partner for Lung Cancer Liquid Biopsy

  • Liquid Biopsy Shows Promise as Screen for Cancers

  • Inivata launches RaDaRT for the detection of residual disease and recurrence

  • Liquid Biopsy Assay Detects 50+ Types of Cancer

  • Liquid Biopsy Study Confirms Concordance with Tissue Biopsy

  • Guardant Health Liquid Biopsy Expands Medicare Coverage

  • Aethlon Medical Lands Grant for Exosome Isolation Device

  • Biolidics to Develop Liquid Biopsy Breast Cancer Test

  • Liquid Biopsy Equal to Tissue to Indicate Immunotherapy Response

  • Exact Sciences buys Genomic Health

  • Multi-Gene Liquid Biopsy Breast Cancer Panel

  • Bio-Techne receives FDA breakthrough device for prostate cancer liquid biopsy

  • Thrive to Develop Earlier Detection of Multiple Cancer Types

  • Guardant Health Liquid Biopsy Test to be Covered by EviCore

  • Liquid biopsy combines Illumina's 'ultradeep' sequencing with Grail's machine learning

  • Biocept Partnership Offering for Liquid Biopsy Adds Several Key Services

  • Natera Commercializes Tumor Whole Exome Sequencing from Plasma

  • Sienna Buys Liquid Biopsy & Exosome Isolation Technology

  • Inivata Completes 39.8M Series B Funding Round

  • Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance

  • CellMax, Medigen Biotech Partner in Colorectal Cancer Clinical Trials

  • Biodesix Acquires Integrated Diagnostics

  • Predicine, Kintor Pharmaceuticals Partner on Clinical Trials, CDx

  • Bio-Techne to Acquire Exosome Dx for Up to $575M

  • GRAIL Announces Data on Detection of Early-Stage Lung Cancers

  • Precision for Medicine Acquires ApoCell

  • NeoGenomics to Acquire Genoptix for Cash, Stocks

  • PGDx Liquid Biopsy Assay to be Used in Cancer Drug Study

  • Liquid Biopsy IDs More NSCLC Mutations in Study of Guardant Test

  • Inivata Gets Draft Medicare Coverage Determination for Lung Cancer Test

5. Profiles of Key Players

  • Abbott Diagnostics

  • AccuraGen Inc

  • Acuamark Diagnostics

  • Admera Health, LLC

  • Agena Bioscience, Inc

  • Agilent

  • Amoy Diagnostics Co., Ltd

  • Anchor Dx

  • ANGLE plc

  • ApoCell, Inc

  • ArcherDx, Inc

  • Asuragen

  • AVIVA Biosciences

  • Baylor Miraca Genetics Laboratories

  • Beckman Coulter, Inc.

  • Becton, Dickinson and Company

  • BGI Genomics Co. Ltd

  • Bioarray Genetics

  • Biocartis

  • Biocept, Inc

  • Biodesix Inc

  • BioFluidica

  • bioMerieux Diagnostics

  • Bioneer Corporation

  • Bio-Rad Laboratories, Inc

  • Bio-Techne

  • Bioview

  • Bolidics

  • Boreal Genomics

  • Caris Molecular Diagnostics

  • CellMax Life

  • Cepheid (now Danaher)

  • Chronix Biomedical

  • Circulogene

  • Clinical Genomics

  • Cynvenio

  • Cytolumina Technologies Corp

  • CytoTrack

  • Datar Cancer Genetics Limited

  • Diagenode Diagnostics

  • Diagnologix LLC

  • Enzo Life Sciences, Inc

  • Epic Sciences

  • Epigenomics AG

  • Eurofins Scientific

  • Exosome Diagnostics

  • Exosome Sciences

  • Fluidigm Corp

  • Fluxion Biosciences

  • Foundation Medicine

  • Freenome

  • GeneFirst Ltd.

  • Genetron Health (Beijing) Co., Ltd

  • Genomic Health

  • GILUPI Nanomedizin

  • Grail, Inc

  • Guardant Health

  • HansaBiomed

  • HeiScreen

  • Helomics

  • Horizon Discovery

  • iCellate

  • Illumina

  • Incell Dx

  • Inivata

  • Integrated Diagnostics

  • Janssen Diagnostics

  • MDNA Life SCIENCES, Inc

  • MDx Health

  • Menarini Silicon Biosystems

  • Millipore Sigma

  • Miltenyi Biotec

  • miR Scientific

  • Molecular MD

  • Myriad Genetics/Myriad RBM

  • NantHealth, Inc

  • Natera

  • NeoGenomics

  • New Oncology

  • Novogene Bioinformatics Technology Co., Ltd

  • Oncocyte

  • OncoDNA

  • Oxford Nanopore Technologies

  • Perkin Elmer

  • Personal Genome Diagnostics

  • PrecisionMed

  • Promega

  • Qiagen Gmbh

  • Quidel

  • Rarecells SAS

  • RareCyte

  • Resolution Biosciences, Inc

  • Roche Molecular Diagnostics

  • Screencell

  • Siemens Healthineers

  • simfo GmbH

  • Singlera Genomics Inc

  • SRI International

  • Sysmex Inostics

  • Tempus Labs, Inc

  • Thermo Fisher Scientific Inc

  • Thrive Earlier Detection

  • Trovagene

  • Volition

6. The Global Market for Liquid Biopsy Diagnostics
6.1 Global Market Overview by Country
6.1.1 Table - Global Market by Country
6.1.2 Chart - Global Market by Country
6.2 Global Market by Cancer - Overview
6.2.1 Table - Global Market by Cancer
6.2.2 Chart - Global Market by Cancer - Base/Final Year Comparison
6.2.3 Chart - Global Market by Cancer - Base Year
6.2.4 Chart - Global Market by Cancer - End Year
6.2.5 Chart - Global Market by Cancer - Share by Year
6.2.6 Chart - Global Market by Cancer - Segments Growth
6.3 Global Market by Usage - Overview
6.3.1 Table - Global Market by Usage
6.3.2 Chart - Global Market by Usage - Base/Final Year Comparison
6.3.3 Chart - Global Market by Usage - Base Year
6.3.4 Chart - Global Market by Usage - End Year
6.3.5 Chart - Global Market by Usage - Share by Year
6.3.6 Chart - Global Market by Usage - Segments Growth

7. Global Liquid Biopsy Diagnostic Markets - By Cancer
7.1 Breast
7.1.1 Table Breast - by Country
7.1.2 Chart - Breast Growth
7.2 Colorectal
7.2.1 Table Colorectal - by Country
7.2.2 Chart - Colorectal Growth
7.3 Cervical
7.3.1 Table Cervical - by Country
7.3.2 Chart - Cervical Growth
7.4 Lung
7.4.1 Table Lung - by Country
7.4.2 Chart - Lung Growth
7.5 Prostate
7.5.1 Table Prostate - by Country
7.5.2 Chart - Prostate Growth
7.6 Other
7.6.1 Table Other - by Country
7.6.2 Chart - Other Growth

8. Global Liquid Biopsy Diagnostic Markets - by Usage
8.1 Screening
8.1.1 Table Screening - by Country
8.1.2 Chart - Screening Growth
8.2 Diagnostic
8.2.1 Table Diagnostic - by Country
8.2.2 Chart - Diagnostic Growth
8.3 Therapy
8.3.1 Table Therapy - by Country
8.3.2 Chart - Therapy Growth
8.4 Monitor
8.4.1 Table Monitor - by Country
8.4.2 Chart - Monitor Growth

For more information about this report visit https://www.researchandmarkets.com/r/j96tl3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Latest Stories

  • Reporter Carl Bernstein names 21 GOP senators who 'repeatedly expressed extreme contempt for Trump'

    Political reporters in Washington, D.C., have been saying a lot of Republicans in Congress privately despise President Trump, but few have publicly criticized him — and likewise, few have publicly acknowledged his defeat to President-elect Joe Biden. Carl Bernstein, one half of the journalistic duo that uncovered President Richard Nixon's Watergate scandal, named 21 names on Sunday night, saying that in private conversations, these Republicans senators "have repeatedly expressed extreme contempt for Trump" and his fitness to be president.> The 21 GOP Senators who have privately expressed their disdain for Trump are: Portman, Alexander, Sasse, Blunt, Collins, Murkowski, Cornyn, Thune, Romney, Braun, Young, Tim Scott, Rick Scott, Rubio, Grassley, Burr, Toomey, McSally, Moran, Roberts, Shelby. (2/3)> > — Carl Bernstein (@carlbernstein) November 23, 2020The 21 senators he named include names you would expect, but also some surprises, like Sen. John Cornyn (Texas), Sen. Rick Scott (Fla.), and Senate Majority Whip John Thune (S.D.). The other 18 GOP senators are Rob Portman (Ohio), Lamar Alexander (Tenn.), Ben Sasse (Neb.), Roy Blunt (Mo.), Susan Collins (Maine), Lisa Murkowski (Alaska), Mitt Romney (Utah), Mike Braun (Ind), Todd Young (Ind.), Tim Scott (S.D.), Marco Rubio (Fla.), Chuck Grassley (Iowa), Richard Burr (N.C.), Pat Toomey (Pa.), Martha McSally (Ariz.), Jerry Moran (Kansas), Pat Roberts (Kansas), and Richard Shelby (Ala.)."With few exceptions" — Romney and Sasse, mostly — "their craven public silence has helped enable Trump's most grievous conduct — including undermining and discrediting the U.S. the electoral system," wrote Bernstein, who's made his own feelings about Trump clear for a while. He had named 15 of those senators on CNN late last week, saying "many, of not most, of these individuals, from what I have been told, were happy to see Donald Trump defeated in this election, as long as the Senate could be controlled by the Republicans.Bernstein added that he is "much more concerned" now than at the end of Watergate, because "Nixon left — Republicans convinced him to go, and he did."More stories from theweek.com 5 bruisingly funny cartoons about Rudy Giuliani's dubious legal strategy Oxford-AstraZeneca's COVID-19 vaccine is at least 70 percent effective in late-stage trial America is buckling

  • Iowa congressman notorious for racist remarks asks Kamala Harris if she was descended from slave owners

    Outgoing Republican Steve King has long history of offensive remarks

  • Hong Kong activist Joshua Wong detained for 2019 illegal assembly

    Hong Kong pro-democracy activist Joshua Wong was remanded in custody on Monday after pleading guilty to charges of organising and inciting an unauthorised assembly near the police headquarters during last year's anti-government protests. Wong, who was just 17 years old when he became the face of the 2014 student-led Umbrella Movement democracy protests, faces a maximum three-year jail term. On Twitter afterwards, Wong said attention should be directed to the 12 Hong Kong people detained virtually incommunicado in China after being arrested at sea in August as they were attempting to flee by boat to Taiwan to escape charges related to last year's protests in the city.

  • Israeli army says Gaza militants fired a rocket at Israel

    Palestinian militants in the Gaza Strip fired a rocket toward Israel on Saturday night, setting off air-raid sirens in the southern Israeli city of Ashkelon, the Israeli military announced. Israeli police said the rocket caused damage to a structure in the Ashkelon area, roughly 10 kilometers (6 miles) north of Gaza, but there were no injuries.

  • Trump legal team planning to file election lawsuit in Georgia

    Trump attorney Jenna Ellis details the team’s post-election legal strategy on ‘Fox & Friends.’

  • Republican Sen. Kelly Loeffler, a candidate in the Georgia runoff, tested positive for COVID-19 and is quarantining

    Loeffler is currently campaigning in a high-stakes race that could determine control of the Senate at the start of President-elect Joe Biden's term.

  • Ronna McDaniel has reportedly warned Donald Trump Jr., Kimberly Guilfoyle could succeed her as RNC chair

    There are members of the Republican Party who are worried that Ronna McDaniel's desire to remain as the chair of the Republican National Committee could mean President Trump will retain control of the group and, therefore, the GOP even after he's out of the White House, The New York Times reports. McDaniel is a close ally of Trump, and wary Republicans suspect she could allow Trump to mobilize the party against incumbents he doesn't consider loyal enough.But McDaniel has reportedly attempted to assure the doubters that she'll remain independent of Trump and his family, four Republicans told the Times on condition of anonymity. Besides, if it's not her, the risk of an even more pro-Trump chair could emerge, she reportedly told one party leader, warning that her successor could be someone like Donald Trump, Jr. or his girlfriend, Kimberly Guilfoyle.Aides to Trump Jr. and Guilfoyle have said neither is interested in the job, but the possibility could be enough for McDaniel to reel in the support she needs, given the party is concerned it could continue to lose its grip on suburban voters. Read more at The New York Times.More stories from theweek.com Reporter Carl Bernstein names 21 GOP senators who 'repeatedly expressed extreme contempt for Trump' 5 bruisingly funny cartoons about Rudy Giuliani's dubious legal strategy Oxford-AstraZeneca's COVID-19 vaccine is at least 70 percent effective in late-stage trial

  • AOC calls out Kyle Rittenhouse's $2 million bail release as 'protection of white supremacy'

    "Does anyone believe Rittenhouse would be released if he were Muslim," AOC wrote on Twitter.

  • Calls for Britain to give asylum to Pakistani Christian girl forced to marry Muslim man who abducted and gang-raped her

    Boris Johnson has been urged to grant asylum to a Pakistani Christian girl who was forced to marry a Muslim man accused of abducting and raping her at gunpoint. The family of the 14-year-old girl claims that she was kidnapped by Mohamad Nakash last year, who used blackmail and threats of violence to make her sign false papers consenting to marriage. In August, a judge's order that she be taken to a women's refuge was overturned by a higher court, which ruled the marriage was legal and returned her to Mr Nakash’s home. The girl then escaped and is now in hiding. But her lawyer claims that associates of Mr Nakash, who turned up en masse at the court hearings, have been trying to hunt her down. The British charity Aid to Church in Need, which campaigns on behalf of persecuted Christians worldwide, has now launched a petition asking the government to grant the girl asylum. “This shocking case is a chance for Britain to show its commitment to Christian welfare who so often feel abandoned by the West, ” said spokesman John Pontifex. The case has echoes of that of Asia Bibi, a Pakistani Christian woman who spent ten years on death row in Pakistan on trumped-up blasphemy charges.

  • Iran vows to crush any Israeli attempt to hit its 'advisory' role in Syria

    Iran on Sunday vowed to defeat any Israeli attempt to harm its role in Syria, saying the era of "hit and run" attacks by Israel there was over, days after Israel carried out air strikes on Syrian army and Iranian paramilitary targets in the country. Israel, which views Tehran as its biggest security threat, has repeatedly attacked Iranian targets and those of allied militia in Syria, where Tehran has backed President Bashar al-Assad and his forces against rebels and militants since 2012. On Wednesday, an Israeli military spokesman said eight targets were attacked, including an Iranian headquarters at Damascus international airport and a "secret military site" that served as a "hosting facility for senior Iranian delegations when they come to Syria to operate".

  • Biden has reportedly chosen his UN ambassador, national security adviser

    President-elect Joe Biden is expected to announce Linda Thomas-Greenfield as his nominee for ambassador to the United Nations and Jake Sullivan as his national security adviser, several people familiar with the matter told The Washington Post. Thomas-Greenfield spent 35 years in the Foreign Service, retiring in 2017. She served as assistant secretary of state for African affairs and was ambassador to Liberia during the Obama administration. She is now a senior counselor with the Albright Stonebridge advisory firm.Sullivan was one of Biden's national security advisers during his time as vice president and was also a deputy chief of staff to Hillary Clinton when she was secretary of state. Antony Blinken, Biden's reported pick to be his secretary of state nominee, also served as one of Biden's national security advisers while vice president.More stories from theweek.com Reporter Carl Bernstein names 21 GOP senators who 'repeatedly expressed extreme contempt for Trump' 5 bruisingly funny cartoons about Rudy Giuliani's dubious legal strategy Oxford-AstraZeneca's COVID-19 vaccine is at least 70 percent effective in late-stage trial

  • A new CDC report found that Kansas counties who complied with a mask mandate saw a decrease in cases compared to counties that didn't

    The CDC found that counties in Kansas that opted out of the statewide mask mandate saw their number of cases jump by 100% over the period studied.

  • Man arrested in deadly attack at Nebraska Sonic restaurant

    Authorities arrested a 23-year-old man in an attack at a Nebraska fast food restaurant in which two employees were shot and killed, two were wounded and officers responding to a report of a possible bomb inside a moving truck in the parking lot arrived to find the vehicle on fire. Roberto Carlos Silva Jr., of Omaha, was booked into Sarpy County jail early Sunday on suspicion of first-degree murder and first-degree arson in Saturday night's attack at a Sonic Drive-in restaurant in Bellevue, the Omaha World-Herald reported. In a news release early Sunday, Lt. Andy Jashinske said Bellevue police received a call at 9:23 p.m. Saturday about a possible bomb in a U-Haul truck parked outside of the restaurant in the Omaha suburb.

  • Convicted spy Jonathan Pollard released from parole and due to move to Israel

    Jonathan Pollard, the former US Navy officer convicted of spying for Israel, has finished his parole and is expected to move to the Jewish state in the near future. Mr Pollard was one of the most prolific spies in US history and had shared thousands of classified documents with Israel during the Cold War. The US Justice Department’s parole commission decided on Friday to allow a travel ban on Mr Pollard to expire after he served 30 years in prison. According to the New York Times, he is the only American to ever be sentenced with life imprisonment for spying on behalf of an ally. The espionage affair strained US-Israel relations for decades. The decision to lift his travel restrictions is being seen as a parting gift to the Israelis from the Trump administration, which has heavily favoured Israel during its term. Benjamin Netanyahu, the Israeli prime minister, has long pushed for the release of Mr Pollard and after granting him Israeli citizenship in 1995, and has tried to bring him to Israel as part of diplomatic negotiations. “The prime minister expects to see Jonathan Pollard in Israel soon, and together with all Israelis, extends his best wishes to him and his wife Esther,” Mr Netanyahu’s office said in a statement on Saturday night. Mr Pollard was a young civilian intelligence analyst for the US Navy and sold military secrets to the Israelis in exchange for thousands of dollars a month while he was working at the Pentagon in the 1980s. A year and a half into his espionage he was arrested by FBI agents in 1985 while trying to claim asylum at the Israeli embassy in Washington. The 66-year-old convicted spy was released from federal prison in 2015 after serving 30 years and placed on parole. A five-year travel ban was placed on him as well as parole conditions including a curfew, restrictions on what jobs he could take and a location tag. "We are grateful and delighted that our client is finally free of any restrictions, and is now a free man in all respects," Mr Pollard’s lawyers said. "We look forward to seeing our client in Israel." His lawyer, Eliot Lauer, told Channel 12 TV that Pollard was “ecstatic” and determined to move to Israel but that it would take some time because Pollard’s wife is undergoing medical treatment for cancer.

  • The women who served as a deadly duo for the Taliban

    Female assassins who lured an Afghan security official to his death with promises of sex before shooting him and dumping his body at a cemetery are among thousands of Taliban criminals freed as part of a fragile peace plan.

  • Republicans launch Pennsylvania lawsuit that argues GOP-backed bill allowing universal mail voting is unconstitutional

    A group of Republicans, including Rep. Mike Kelly (R-Pa.) are launching a lawsuit -- in the hopes of blocking the certification of Pennsylvania's election results -- that claims a state law passed in 2019 allowing for universal mail-in voting is unconstitutional. If that were the case, mail-in ballots would be invalidated, likely swinging the state back to President Trump.> Here is the complaint introduction from the Commonwealth Court filing /5 pic.twitter.com/OdF3hdUpwS> > -- Matt Maisel (@Matt_Maisel) November 21, 2020The lawsuit quickly drew heated criticism, including accusations that Kelly (who was just re-elected himself) and the other plaintiffs are "openly rejecting democracy and the rule of law," but many observers were simply perplexed. For starters, the bill was passed over a year ago, raising questions as to why its constitutionality wasn't brought up between then and now. Plus, it was pushed through thanks to a majority GOP state legislature, with only one Republican member of the state House voting against it, while GOP senators backed it unanimously. > In the lawsuit, filed this morning in Commonwealth Court, plaintiffs say Act 77 is "unconstitutional," and "implemented illegally." They argue it's an illegal attempt to override limitations on absentee voting, and needed to go through a constitutional amendment first /3> > -- Matt Maisel (@Matt_Maisel) November 21, 2020More stories from theweek.com Reporter Carl Bernstein names 21 GOP senators who 'repeatedly expressed extreme contempt for Trump' 5 bruisingly funny cartoons about Rudy Giuliani's dubious legal strategy Oxford-AstraZeneca's COVID-19 vaccine is at least 70 percent effective in late-stage trial

  • Biden chief of staff says inauguration ‘not going to be the same’

    Ron Klain said the inauguration ceremony will be altered to prevent the spread of coronavirus.

  • Wisconsin police arrest 15-year-old boy for Mayfair Mall shooting, say 'bullets started flying' during altercation

    While witnesses described the shooter as a white man in his 20s or 30s, Wauwatosa Police Chief Barry Weber said the suspect is an Hispanic teenager.

  • A bipartisan group of Georgia teens is trying to flip the Senate by enlisting thousands of students to vote in the January runoffs

    The group hopes to register the 23,000 Georgia teens who could not vote in the general election but turn 18 in time to vote in the Senate runoffs.

  • Thousands attack Brazil supermarket amid violent protests after black man beaten to death by security guard

    More than 1,000 demonstrators attacked a Carrefour Brasil supermarket in the southern Brazilian city of Porto Alegre on Friday after security guards beat to death a Black man at the store. The killing, which has sparked protests across Brazil, occurred late on Thursday when a store employee called security after the man threatened to attack her, cable news channel GloboNews said, citing the Rio Grande do Sul state military police. Amateur footage of the fatal beating and tributes to the Black victim were published on social media. He was identified in local media by his father as 40-year-old Joao Alberto Silveira Freitas. News website G1 later reported that an initial analysis by the state forensics institute indicated the cause of death could be asphyxiation. In a statement on Friday, the local unit of France's Carrefour SA said it deeply regretted what it called a brutal death and said it immediately took steps to ensure those responsible were legally punished. It said it would terminate the contract with the security firm, fire the employee in charge of the store at the time of the incident, and close the store as a mark of respect.